Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 14.57 CNY 0.76% Market Closed
Market Cap: 21.8B CNY
Have any thoughts about
Tasly Pharmaceutical Group Co Ltd?
Write Note

Tasly Pharmaceutical Group Co Ltd
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tasly Pharmaceutical Group Co Ltd
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Other
-ÂĄ9.5m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
40%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other
-ÂĄ5.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other
-ÂĄ33.4m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other
-ÂĄ270m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other
-ÂĄ101.2m
CAGR 3-Years
N/A
CAGR 5-Years
51%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other
-ÂĄ98.3m
CAGR 3-Years
-70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tasly Pharmaceutical Group Co Ltd
Glance View

Market Cap
21.8B CNY
Industry
Pharmaceuticals

Tasly Pharmaceutical Group Co., Ltd. engages in the development, manufacture and distribution of pharmaceutical products. The company is headquartered in Tianjin, Tianjin and currently employs 9,437 full-time employees. The company went IPO on 2002-08-23. The firm's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The firm's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The firm mainly distributes its products in the domestic market.

Intrinsic Value
19.8 CNY
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Tasly Pharmaceutical Group Co Ltd's Other?
Other
-9.5m CNY

Based on the financial report for Jun 30, 2024, Tasly Pharmaceutical Group Co Ltd's Other amounts to -9.5m CNY.

What is Tasly Pharmaceutical Group Co Ltd's Other growth rate?
Other CAGR 10Y
40%

Over the last year, the Other growth was 99%. The average annual Other growth rates for Tasly Pharmaceutical Group Co Ltd have been 67% over the past three years , and 40% over the past ten years .

Back to Top